Abstract
TechNavio's analysts forecast the Global Human Vaccines market to reach US$57.6 billion by 2015. One of the key factors contributing to this market growth is the increase in demand for vaccination against communicable diseases. The Global Human Vaccines market has also been witnessing the increase in awareness programs worldwide. However, emergence of vaccine-resistant viruses could pose a challenge to the growth of this market.
TechNavio's report, the Global Human Vaccines Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include GlaxoSmithKline plc, Merck and Co. Inc., Pfizer Inc., and Sanofi S.A. Other vendors mentioned in the report:: ALK Abello A/S, AstraZeneca plc, Bavarian Nordic A/S, Baxter International Inc., CSL Ltd., MedImmune Inc., Novartis AG, Shanta Biotechnics Ltd., Sinovac Biotech Ltd., and Vaxin Inc.
Key questions answered in this report:
- What will the market size be in 2015 and at what rate will it grow?
- What key trends is this market subject to?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the opportunities and threats faced by each of these key vendors?
- What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
Table of Contents
01. Executive Summary
02. Introduction
03. Market Coverage
- Market Overview
- Key Products
04. Market Landscape
- Market Size
- Market Segmentation by Vaccine Application
- Market Segmentation by Consumers
- Market Size of Global Pediatric Vaccines Market
- Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
- Drivers and their Impact: End-users
- Drivers and their Impact: Geography
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
- 15.1. GlaxoSmithKline plc
- Business Overview
- SWOT Analysis
- 15.2. Sanofi S.A.
- Business Overview
- SWOT Analysis 32
- 15.3. Pfizer Inc.
- Business Overview
- SWOT Analysis
- 15.4. Merck and Co. Inc.
- Business Overview
- SWOT Analysis
16. Other Reports in this Series
List of Exhibits:
- Exhibit 1: Global Human Vaccines Market 2011-2015 (US$ billion)
- Exhibit 2: Global Human Vaccines Market Segmentation
- Exhibit 3: Global Human Vaccines Market Segmentation by Application 2011
- Exhibit 4: Global Human Vaccines Market Segmentation by Consumers 2011
- Exhibit 5: Global Pediatric Vaccines Market 2011-2015 (US$ billion)
- Exhibit 6: Global Human Vaccines Market by Geographical Segmentation 2011
- Exhibit 7: Hepatitis C Infection by Source in 2011
- Exhibit 8: Global Human Vaccines Market by Vendor Segmentation 2011
Global Human Vaccines Market 2011-2015 published by Infiniti Research Limited (Technavio) in June 13, 2012. This report consists of Pages: 42 and the price starts from US $ 1500.
